F. Hoffmann-La Roche Ltd. (Roche) is a biotechnology company that develops drugs and diagnostics to treat major diseases, headquartered in Switzerland with global manufacturing and sales reach. Roche provides pharmaceuticals in oncology, immunology, neuroscience, ophthalmology, infectious diseases, respiratory and other therapeutic areas. The company also provides in vitro diagnostics and tissue-based cancer diagnostics, as well as diabetes management solutions. The report, COVID-19 Impact on F. Hoffmann-La Roche Ltd.'s Revenue and Operations (Medical Devices) presents a deep dive analysis into how F. Hoffmann-La Roche Ltd. is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
The report provides a comprehensive analysis of the impact of COVID-19 on F. Hoffmann-La Roche Ltd. –
– It provides insights on F. Hoffmann-La Roche Ltd.'s exposure to the regions and businesses impacted by the COVID-19 outbreak.
– It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.
The spread of the disease in recent months has caused volatility in some markets, but has had a limited impact on Roche’s business performance.
Roche announced that during Q3 2020, Diagnostic Division sales grew 9% compared to Q1 2019 with a 29% growth in sales of molecular testing as the main contributor. Roche launched several new diagnostic tools in the fight against COVID-19: the SARS-CoV-2 rapid antigen test, cobas SARS-CoV-2 & influenza A/B test and Elecsys AntiSARS-CoV-2 S antibody test. Roche's SARS-CoV-2 & Influenza A/B Test for use on the cobas® 6800/8800 Systems has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA)
Reasons to Buy
An overview of how F. Hoffmann-La Roche Ltd. will be affected by the COVID-19 pandemic.
F. Hoffmann-La Roche Ltd.
Table of Contents
Table of Contents
COVID-19 impact analysis on Roche – Key Findings
Roche Key Facts
Geographic spread analysis – COVID-19 vs Roche sales
The impact of COVID-19 on regional GDP per capita levels
Roche's exposure: revenues by region and market vs regional impact levels
Roche's : revenue impact by region and market for 2020
Operational reactions from Roche? Indications from recruitment trends
Operational reactions from Roche’s Indications from US pricing trends